<qa>  What is the goal of the trial?The goal of this trial is to determine whether oral continuous metronomic therapy with trofosfamide results in a similar rate of progression-free time after 6 months as intravenous treatment with adriamycin. In addition, the study is intended to investigate the level of toxicity associated with the two treatment regimens safety profile. 